重度哮喘的多维评估:系统综述与荟萃分析
该系统综述纳入26项研究,分析重度哮喘多维评估(MDA)所涵盖的特征及其对哮喘相关结局的影响。MDA评估的特征分为气道、共病和危险因素三个领域,其中气道领域评估的特征数量最多。6项结局研究中5项认为MDA能改善哮喘相关结局,但需更多研究明确应评估和治疗哪些特征。
要点
- MDA评估气道、共病和危险因素三个领域,气道领域特征数最多。
- 支气管舒张可逆性和气流受限在92%的研究中评估,气道炎症仅50%。
- 6项结局研究中5项认为MDA改善哮喘相关结局,但需更多研究。
核心结论
- MDA研究评估了多种不同特征,并显示出改善结局的证据,但需更多研究明确应评估和治疗哪些特征及MDA对患者结局的影响。
研究设计与样本
- 系统综述与荟萃分析,纳入26项研究,按研究类型分为队列/横断面研究、实验/结局研究和重度哮喘疾病登记研究。
主要发现
- 气道领域评估的特征数量最多(均值±标准差=4.2±1.7),共病领域为3.6±2.2,危险因素领域为3.9±2.1。
- 支气管舒张可逆性和气流受限在92%的研究中评估,气道炎症仅在50%的研究中评估。
- 常见共病为心理功能障碍和鼻窦炎(均73%)及胃食管反流病(GORD;69%)。
- 特应性和吸烟状态是最常评估的危险因素(分别为85%和86%)。
- 6项结局研究中5项结论为MDA能有效改善哮喘相关结局,且这些研究中评估的特征显著多于治疗的特征。
临床怎么用
- 临床可参考MDA模式对重度哮喘进行多维度评估,涵盖气道、共病和危险因素三个领域。
- 评估时应关注支气管舒张可逆性、气流受限、心理功能障碍、鼻窦炎、GORD、特应性和吸烟状态等常见特征。
局限性
- 支持MDA的前瞻性研究较少。
- 研究类型决定评估的全面性,各研究评估的特征种类不同。
- 需更多研究明确应评估和治疗哪些特征及MDA对患者结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The management of severe asthma is complex. Multidimensional assessment (MDA) of specific traits has been proposed as an effective strategy to manage severe asthma, although it is supported by few prospective studies. We aimed to systematically review the literature published on MDA in severe asthma, to identify the traits included in MDA and to determine the effect of MDA on asthma-related outcomes. We identified 26 studies and classified these based on study type (cohort/cross-sectional studies; experimental/outcome studies; and severe asthma disease registries). Study type determined the comprehensiveness of the assessment. Assessed traits were classified into three domains (airways, co-morbidities and risk factors). The airway domain had the largest number of traits assessed (mean ± SD = 4.2 ± 1.7) compared with co-morbidities (3.6 ± 2.2) and risk factors (3.9 ± 2.1). Bronchodilator reversibility and airflow limitation were assessed in 92% of studies, whereas airway inflammation was only assessed in 50%. Commonly assessed co-morbidities were psychological dysfunction, sinusitis (both 73%) and gastro-oesophageal reflux disease (GORD; 69%). Atopic and smoking statuses were the most commonly assessed risk factors (85% and 86%, respectively). There were six outcome studies, of which five concluded that MDA is effective at improving asthma-related outcomes. Among these studies, significantly more traits were assessed than treated. MDA studies have assessed a variety of different traits and have shown evidence of improved outcomes. This promising model of care requires more research to inform which traits should be assessed, which traits should be treated and what effect MDA has on patient outcomes.
引用
- Clark VL, Gibson PG, Genn G, et al. Multidimensional assessment of severe asthma: A systematic review and meta-analysis. Respirology. 2017. PMID: 28776330. doi:10.1111/resp.13134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。